Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
05 September 2019 | Story Prof Francis Petersen (UFS Rector and Vice-Chancellor)

In light of the ongoing violence against women, and recent surge in femicide in South Africa, the University of the Free State (UFS) recommits itself to challenge, fight and eradicate all forms of gender-based violence on its campus and in the country.

The recent rape and murder of 19-year-old Media and Film Studies student at the University of Cape Town (UCT), Uyinene Mrwetyana, and the murder of University of the Western Cape (UWC) student, Jesse Hess, are painful reminders of the pervasive nature of misogyny and patriarchal violence that impedes the freedom of women/womxn in South Africa. The UFS stands in solidarity with UCT and UWC, and all other South African universities that are currently steeped in this national crisis pertaining to gender-based violence.

The UFS perceives this as an enduring manifestation of patriarchy that results in women’s/womxn’s subordination, inequality, and violation of bodily integrity. These horrific events underscore the extent to which attempts to address women’s/womxn’s inequality and gender-based violence nationally, and more pertinently at universities, have failed. Recent discussions have underscored the issue of ‘belonging’ as a concern in Higher Education contexts. Belonging is often couched in the language of ‘access’ and ‘transformation’. However, these terms often provide limited substantive change for students who experience a sense of marginalisation and alienation at South African universities. Decolonisation discourse challenges the nature of hegemonic knowledge production that excludes voices of alterity.

Epistemic violence is central to decolonisation discourse referring to the nature of hegemonic knowledge production that excludes voices of alterity. The extent to which knowledge production manifests in universities is, however, not only white and Western, but also male and masculine. South African universities are therefore confronted again with the urgency of recognising and responding to the issue of women’s/womxn’s subordination, with specific emphasis on their safety and freedom.

The UFS is committed to creating a university space where all our students feel that they belong, by broadening current epistemologies and including women’s/womxn’s voices and lived experiences. More pertinently and in a practical manner, curriculum change should include diverse intellectual perspectives and incorporate an ethics of care in teaching practices. The UFS acknowledges that more must be done as a space of higher learning to investigate the causes that underlie the continuance of sexual violence against women/womxn.

On Friday 6 September 2019, the UFS held a day of mourning, standing in solidarity with other universities in their attempt to respond to the present crisis. In mourning Uyinene and Jesse’s death and all other victims and survivors of gender-based violence, the university will critically self-reflect on the multi-layered demand for transformation and consciousness needed for deep change.

The UFS calls on the Department of Higher Education, civil society, the business sector and all others to actively contribute to efforts that will eradicate gender violence. As the UFS, we call specifically on the City of Bloemfontein, the mayor, members of local government, South Africa Police Service and all inhabitants to assist us in making the city safe for all.

Prof Francis Petersen
Rector and Vice-Chancellor
University of the Free State
5 September 2019


News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept